• Institute of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical College. Guangzhou, Guangdong, 510120, China;
XU Jun, Email: xufeili@vip.163.com
Export PDF Favorites Scan Get Citation

Objective  To investigate the expression of high mobility group protein-B1( HMGB1)and α-smooth muscle actin( α-SMA) in Bleomycin induced pulmonary fibrosis in mice. Methods  Twenty C57BL/ 6 male mice were randomly divided into a Bleomycin group and a control group. The Bleomycin group was treated with Bleomycin( 3 mg/kg) by endotracheally injection to induce pulmonary fibrosis. The control group were treated with normal saline( NS) . Then they were sacrificed by abdominal aortic bleeding 10 days after the injection. The right lung was stained with hematoxylin-eosin and Masson trichrome respectively for pathological examination. Immunohistochemistry and RT-PCR were performed to identify the protein and mRNA levels of α-SMA and HMGB1 respectively. Results  The mRNA( 0. 89 ±0. 12, 0. 61 ±0. 08) and protein( 13. 66 ±1. 01, 13. 12 ±1. 33) expressions of α-SMA and HMGB1 in the Bleomycin group were all significantly higher than those of the control group( mRNA: 0. 60 ±0. 07, 0. 15 ±0. 02; protein: 8. 18 ±1. 33,7. 92 ±1. 10; all P  lt; 0. 01) . Conclusions  The expressions of HMGB1 and α-SMA are increased in Bleomycin induced pulmonary fibrosis. HMGB1 participates in the pathological process of pulmonary fibrosis probably by activation of the α-SMA expression.

Citation: CAI Lin ,LI Li,XU Jun. The Expression of High Mobility Group Protein-B1 and Alpha-Smooth Muscle Actin in Lung Tissues of Pulmonary Fibrosis Mice. Chinese Journal of Respiratory and Critical Care Medicine, 2009, 09(2): 181-185. doi: Copy

Copyright © the editorial department of Chinese Journal of Respiratory and Critical Care Medicine of West China Medical Publisher. All rights reserved

  • Previous Article

    Assessment of Registration Quality of Trials Sponsored by China
  • Next Article

    Organ Transplantation and Brain Death Legislation in China: Current Status and Challenges